

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 4.86514025 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.73884963 |
| 3 | respiratory burst (GO:0045730) | 4.02277466 |
| 4 | response to peptidoglycan (GO:0032494) | 3.90988820 |
| 5 | protein neddylation (GO:0045116) | 3.87443329 |
| 6 | positive regulation of interferon-alpha production (GO:0032727) | 3.77993779 |
| 7 | signal peptide processing (GO:0006465) | 3.72263440 |
| 8 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.64219341 |
| 9 | xenobiotic catabolic process (GO:0042178) | 3.60559065 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.60068401 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.60068401 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.60068401 |
| 13 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.60068401 |
| 14 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.60068401 |
| 15 | modulation by symbiont of host immune response (GO:0052553) | 3.60068401 |
| 16 | regulation of interferon-alpha production (GO:0032647) | 3.57196662 |
| 17 | response to interferon-beta (GO:0035456) | 3.55457126 |
| 18 | cellular response to interferon-beta (GO:0035458) | 3.48367667 |
| 19 | reactive oxygen species biosynthetic process (GO:1903409) | 3.44977174 |
| 20 | T-helper 1 type immune response (GO:0042088) | 3.44877469 |
| 21 | type I interferon signaling pathway (GO:0060337) | 3.40847053 |
| 22 | cellular response to type I interferon (GO:0071357) | 3.40847053 |
| 23 | response to type I interferon (GO:0034340) | 3.36334002 |
| 24 | aldehyde catabolic process (GO:0046185) | 3.34979964 |
| 25 | granulocyte activation (GO:0036230) | 3.30251819 |
| 26 | eosinophil chemotaxis (GO:0048245) | 3.26982425 |
| 27 | neutrophil activation (GO:0042119) | 3.22479292 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14707429 |
| 29 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.08600835 |
| 30 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.06532464 |
| 31 | platelet dense granule organization (GO:0060155) | 3.05722105 |
| 32 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04746362 |
| 33 | protein maturation by protein folding (GO:0022417) | 3.04715824 |
| 34 | superoxide anion generation (GO:0042554) | 3.03448992 |
| 35 | regulation of activation of Janus kinase activity (GO:0010533) | 3.02708046 |
| 36 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.01715812 |
| 37 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.00626572 |
| 38 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.00169842 |
| 39 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.96404973 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 2.96073577 |
| 41 | peptide catabolic process (GO:0043171) | 2.94560726 |
| 42 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.94287011 |
| 43 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.94199718 |
| 44 | lipoxygenase pathway (GO:0019372) | 2.94027677 |
| 45 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93263145 |
| 46 | eosinophil migration (GO:0072677) | 2.92976919 |
| 47 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90412574 |
| 48 | defense response to protozoan (GO:0042832) | 2.89277778 |
| 49 | autophagic vacuole fusion (GO:0000046) | 2.88607511 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 2.87414832 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 2.87114072 |
| 52 | cyclooxygenase pathway (GO:0019371) | 2.86571176 |
| 53 | glutathione metabolic process (GO:0006749) | 2.84589776 |
| 54 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84197648 |
| 55 | phagosome maturation (GO:0090382) | 2.84094458 |
| 56 | L-phenylalanine catabolic process (GO:0006559) | 2.83496940 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.83496940 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 2.82882309 |
| 59 | hydrogen peroxide catabolic process (GO:0042744) | 2.81425463 |
| 60 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81046909 |
| 61 | regulation of RIG-I signaling pathway (GO:0039535) | 2.80551559 |
| 62 | cellular response to exogenous dsRNA (GO:0071360) | 2.79624830 |
| 63 | mitochondrial calcium ion transport (GO:0006851) | 2.75636979 |
| 64 | glutathione derivative biosynthetic process (GO:1901687) | 2.74730361 |
| 65 | glutathione derivative metabolic process (GO:1901685) | 2.74730361 |
| 66 | negative regulation of viral genome replication (GO:0045071) | 2.72363730 |
| 67 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.70919939 |
| 68 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.70919939 |
| 69 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.69982951 |
| 70 | respiratory electron transport chain (GO:0022904) | 2.69287131 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.68885216 |
| 72 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.68463324 |
| 73 | myeloid cell activation involved in immune response (GO:0002275) | 2.68327483 |
| 74 | L-ascorbic acid metabolic process (GO:0019852) | 2.68185319 |
| 75 | aromatic amino acid family catabolic process (GO:0009074) | 2.68046253 |
| 76 | positive regulation of interferon-beta production (GO:0032728) | 2.68012186 |
| 77 | amino sugar catabolic process (GO:0046348) | 2.67926827 |
| 78 | electron transport chain (GO:0022900) | 2.67589074 |
| 79 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.67065981 |
| 80 | microglial cell activation (GO:0001774) | 2.65647999 |
| 81 | glycolipid catabolic process (GO:0019377) | 2.63607644 |
| 82 | regulation of chemokine biosynthetic process (GO:0045073) | 2.63544380 |
| 83 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.60918328 |
| 84 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.60280213 |
| 85 | GDP-mannose metabolic process (GO:0019673) | 2.59566024 |
| 86 | L-phenylalanine metabolic process (GO:0006558) | 2.59464955 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.59464955 |
| 88 | response to interferon-alpha (GO:0035455) | 2.58666858 |
| 89 | natural killer cell mediated immunity (GO:0002228) | 2.58027311 |
| 90 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.58027311 |
| 91 | response to protozoan (GO:0001562) | 2.56842692 |
| 92 | hydrogen peroxide metabolic process (GO:0042743) | 2.56431294 |
| 93 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.56074331 |
| 94 | amyloid precursor protein catabolic process (GO:0042987) | 2.55336355 |
| 95 | leukocyte mediated cytotoxicity (GO:0001909) | 2.55078934 |
| 96 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.53959616 |
| 97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.53854392 |
| 98 | regulation of antigen processing and presentation (GO:0002577) | 2.52921894 |
| 99 | detection of molecule of bacterial origin (GO:0032490) | 2.52854926 |
| 100 | NAD biosynthetic process (GO:0009435) | 2.52424835 |
| 101 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.52136211 |
| 102 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.52136211 |
| 103 | angiotensin maturation (GO:0002003) | 2.51618892 |
| 104 | glucuronate metabolic process (GO:0019585) | 2.51372734 |
| 105 | uronic acid metabolic process (GO:0006063) | 2.51372734 |
| 106 | protein complex biogenesis (GO:0070271) | 2.51328410 |
| 107 | viral protein processing (GO:0019082) | 2.50005706 |
| 108 | indole-containing compound catabolic process (GO:0042436) | 2.49565329 |
| 109 | indolalkylamine catabolic process (GO:0046218) | 2.49565329 |
| 110 | tryptophan catabolic process (GO:0006569) | 2.49565329 |
| 111 | ceramide catabolic process (GO:0046514) | 2.48348362 |
| 112 | ATP synthesis coupled proton transport (GO:0015986) | 2.48069960 |
| 113 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.48069960 |
| 114 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.47766429 |
| 115 | regulation of cholesterol esterification (GO:0010872) | 2.47282235 |
| 116 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.46957515 |
| 117 | cellular response to zinc ion (GO:0071294) | 2.46582189 |
| 118 | thrombin receptor signaling pathway (GO:0070493) | 2.45940483 |
| 119 | positive regulation of lymphocyte migration (GO:2000403) | 2.45118069 |
| 120 | cofactor catabolic process (GO:0051187) | 2.44527626 |
| 121 | extracellular fibril organization (GO:0043206) | 2.44301174 |
| 122 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.44292017 |
| 123 | response to host immune response (GO:0052572) | 2.44252005 |
| 124 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.44252005 |
| 125 | negative regulation of interleukin-17 production (GO:0032700) | 2.44005655 |
| 126 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.43601160 |
| 127 | positive regulation of mast cell activation (GO:0033005) | 2.43287932 |
| 128 | macrophage activation (GO:0042116) | 2.43257485 |
| 129 | positive regulation of interleukin-17 production (GO:0032740) | 2.42341584 |
| 130 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.42217549 |
| 131 | positive regulation of mast cell degranulation (GO:0043306) | 2.42217549 |
| 132 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.41610682 |
| 133 | deoxyribonucleotide catabolic process (GO:0009264) | 2.41154658 |
| 134 | tryptophan metabolic process (GO:0006568) | 2.38577054 |
| 135 | myeloid dendritic cell activation (GO:0001773) | 2.38283095 |
| 136 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.38162792 |
| 137 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.38087189 |
| 138 | glutathione biosynthetic process (GO:0006750) | 2.37633777 |
| 139 | regulation of interleukin-17 production (GO:0032660) | 2.37633483 |
| 140 | barbed-end actin filament capping (GO:0051016) | 2.37334947 |
| 141 | oligosaccharide catabolic process (GO:0009313) | 2.36875047 |
| 142 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.36660688 |
| 143 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.36221821 |
| 144 | high-density lipoprotein particle remodeling (GO:0034375) | 2.35667155 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.35436811 |
| 146 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.35436811 |
| 147 | neutrophil mediated immunity (GO:0002446) | 2.34978166 |
| 148 | myeloid dendritic cell differentiation (GO:0043011) | 2.34527725 |
| 149 | valine metabolic process (GO:0006573) | 2.34006567 |
| 150 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.33932559 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.33646782 |
| 152 | regulation of hypersensitivity (GO:0002883) | 2.33471430 |
| 153 | adenosine receptor signaling pathway (GO:0001973) | 2.33100929 |
| 154 | virion attachment to host cell (GO:0019062) | 2.33078964 |
| 155 | adhesion of symbiont to host cell (GO:0044650) | 2.33078964 |
| 156 | T cell migration (GO:0072678) | 2.33070977 |
| 157 | regulation of mast cell activation (GO:0033003) | 2.32881257 |
| 158 | response to muramyl dipeptide (GO:0032495) | 2.32830744 |
| 159 | regulation of vacuole organization (GO:0044088) | 2.30496850 |
| 160 | fibril organization (GO:0097435) | 2.30161130 |
| 161 | reverse cholesterol transport (GO:0043691) | 2.26281907 |
| 162 | sequestering of actin monomers (GO:0042989) | 2.24485888 |
| 163 | negative regulation of cation channel activity (GO:2001258) | 2.23877312 |
| 164 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.23118328 |
| 165 | transferrin transport (GO:0033572) | 2.22267475 |
| 166 | arachidonic acid metabolic process (GO:0019369) | 2.22161185 |
| 167 | cytochrome complex assembly (GO:0017004) | 2.21508555 |
| 168 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.20830599 |
| 169 | glycoside metabolic process (GO:0016137) | 2.20181198 |
| 170 | deoxyribose phosphate catabolic process (GO:0046386) | 2.20154064 |
| 171 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.19011996 |
| 172 | peptide metabolic process (GO:0006518) | 2.18099565 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.16212288 |
| 174 | cellular response to cadmium ion (GO:0071276) | 2.16177001 |
| 175 | sphingolipid catabolic process (GO:0030149) | 2.15174466 |
| 176 | regulation of mast cell degranulation (GO:0043304) | 2.14394481 |
| 177 | positive regulation of TOR signaling (GO:0032008) | 2.13784638 |
| 178 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.13582018 |
| 179 | metallo-sulfur cluster assembly (GO:0031163) | 2.13502085 |
| 180 | iron-sulfur cluster assembly (GO:0016226) | 2.13502085 |
| 181 | lysosome organization (GO:0007040) | 2.13436050 |
| 182 | lytic vacuole organization (GO:0080171) | 2.13436050 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.90735571 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.52557666 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09855974 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.36008373 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82253567 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.74406714 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.32306555 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.31383123 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.97586341 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.91098049 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.85001894 |
| 12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.79887319 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.71774635 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.62145232 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.56257573 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.52980369 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.46552393 |
| 18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.42045935 |
| 19 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.33940305 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.32241808 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.29024273 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 2.22160607 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.21581618 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.19882423 |
| 25 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.14831400 |
| 26 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14726245 |
| 27 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.14600951 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13526704 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.00987473 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96530037 |
| 31 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.87920778 |
| 32 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84784981 |
| 33 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.81516617 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.81455463 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.80714729 |
| 36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78445774 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.75592609 |
| 38 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.75500441 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.75150358 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.71550620 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.59507184 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59164714 |
| 43 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.56601625 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.56257172 |
| 45 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.55634932 |
| 46 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54384627 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.51372661 |
| 48 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.50279026 |
| 49 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.49413485 |
| 50 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45638880 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42963855 |
| 52 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40101578 |
| 53 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.38284345 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.36797304 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.36041145 |
| 56 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34699318 |
| 57 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.33457014 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.33410313 |
| 59 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.32891838 |
| 60 | * YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.32791098 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.32111083 |
| 62 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31891802 |
| 63 | P68_20966046_ChIP-Seq_HELA_Human | 1.29677590 |
| 64 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.28050694 |
| 65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26317171 |
| 66 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25450139 |
| 67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25400631 |
| 68 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24747016 |
| 69 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23770032 |
| 70 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22988589 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22686880 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21793169 |
| 73 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21388570 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20705467 |
| 75 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.20256079 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.20033824 |
| 77 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.19803652 |
| 78 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19608760 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.18292971 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.17570886 |
| 81 | * P300_27268052_Chip-Seq_Bcells_Human | 1.17487435 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.16921149 |
| 83 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.15583371 |
| 84 | MYB_26560356_Chip-Seq_TH2_Human | 1.15077381 |
| 85 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15007514 |
| 86 | GATA3_26560356_Chip-Seq_TH2_Human | 1.14678478 |
| 87 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.13999069 |
| 88 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13844636 |
| 89 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13763170 |
| 90 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.12772017 |
| 91 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11495336 |
| 92 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11313495 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09308638 |
| 94 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.08893184 |
| 95 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.08629779 |
| 96 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08315339 |
| 97 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07343946 |
| 98 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.06575375 |
| 99 | * RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.05794725 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.05669702 |
| 101 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03286213 |
| 102 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.01688596 |
| 103 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01193270 |
| 104 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00247760 |
| 105 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.99301918 |
| 106 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99216769 |
| 107 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96533419 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95763790 |
| 109 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94608177 |
| 110 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.94499359 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.91186172 |
| 112 | MYB_26560356_Chip-Seq_TH1_Human | 0.89025227 |
| 113 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.87807101 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87363644 |
| 115 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.85016426 |
| 116 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.84340352 |
| 117 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.83124216 |
| 118 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82187592 |
| 119 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82187592 |
| 120 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.82069001 |
| 121 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.81420389 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80889738 |
| 123 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79164725 |
| 124 | MAF_26560356_Chip-Seq_TH1_Human | 0.78370604 |
| 125 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77962389 |
| 126 | SPI1_23127762_ChIP-Seq_K562_Human | 0.76519667 |
| 127 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.75781640 |
| 128 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74306341 |
| 129 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.73703807 |
| 130 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.72835402 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.72339599 |
| 132 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.71703728 |
| 133 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.69581050 |
| 134 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68488536 |
| 135 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.68483998 |
| 136 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.68264727 |
| 137 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.66867473 |
| 138 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.66841479 |
| 139 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.65442608 |
| 140 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.62990229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.87488308 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.49229306 |
| 3 | MP0002148_abnormal_hypersensitivity_rea | 3.35613344 |
| 4 | MP0009785_altered_susceptibility_to | 3.27037089 |
| 5 | MP0003436_decreased_susceptibility_to | 3.19585002 |
| 6 | MP0003724_increased_susceptibility_to | 3.18809396 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.85408103 |
| 8 | MP0006082_CNS_inflammation | 2.80986601 |
| 9 | MP0002419_abnormal_innate_immunity | 2.68430605 |
| 10 | MP0005025_abnormal_response_to | 2.61567904 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.61198450 |
| 12 | MP0008004_abnormal_stomach_pH | 2.60497006 |
| 13 | MP0005387_immune_system_phenotype | 2.46682582 |
| 14 | MP0001790_abnormal_immune_system | 2.46682582 |
| 15 | MP0003195_calcinosis | 2.40695750 |
| 16 | MP0005671_abnormal_response_to | 2.39594095 |
| 17 | MP0000685_abnormal_immune_system | 2.30617216 |
| 18 | MP0009840_abnormal_foam_cell | 2.18749418 |
| 19 | MP0005365_abnormal_bile_salt | 2.17190993 |
| 20 | MP0005360_urolithiasis | 2.15899985 |
| 21 | MP0002723_abnormal_immune_serum | 2.11341316 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.09367121 |
| 23 | MP0003186_abnormal_redox_activity | 2.07912117 |
| 24 | MP0001800_abnormal_humoral_immune | 2.01855552 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 2.01396254 |
| 26 | MP0009764_decreased_sensitivity_to | 1.98807023 |
| 27 | MP0008469_abnormal_protein_level | 1.89460495 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.88840716 |
| 29 | MP0003191_abnormal_cellular_cholesterol | 1.85972217 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.83449014 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.81000796 |
| 32 | MP0001845_abnormal_inflammatory_respons | 1.80215818 |
| 33 | MP0001819_abnormal_immune_cell | 1.78579222 |
| 34 | MP0001533_abnormal_skeleton_physiology | 1.77658500 |
| 35 | MP0002420_abnormal_adaptive_immunity | 1.76158009 |
| 36 | MP0006036_abnormal_mitochondrial_physio | 1.71982756 |
| 37 | MP0001853_heart_inflammation | 1.61688054 |
| 38 | MP0003879_abnormal_hair_cell | 1.61462415 |
| 39 | MP0005083_abnormal_biliary_tract | 1.59993450 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.59934389 |
| 41 | MP0002405_respiratory_system_inflammati | 1.53133747 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.51248991 |
| 43 | MP0003303_peritoneal_inflammation | 1.43880183 |
| 44 | MP0002837_dystrophic_cardiac_calcinosis | 1.39481549 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.39299658 |
| 46 | MP0003252_abnormal_bile_duct | 1.35972155 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.34621041 |
| 48 | MP0002653_abnormal_ependyma_morphology | 1.34395740 |
| 49 | MP0001764_abnormal_homeostasis | 1.32978201 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.32596351 |
| 51 | MP0004147_increased_porphyrin_level | 1.31438915 |
| 52 | MP0005670_abnormal_white_adipose | 1.29756094 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.29159270 |
| 54 | MP0000716_abnormal_immune_system | 1.28976221 |
| 55 | MP0008260_abnormal_autophagy | 1.28506512 |
| 56 | MP0000343_altered_response_to | 1.27934252 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.27176895 |
| 58 | MP0010329_abnormal_lipoprotein_level | 1.26417481 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.24774150 |
| 60 | MP0003075_altered_response_to | 1.24747662 |
| 61 | MP0005332_abnormal_amino_acid | 1.23387193 |
| 62 | MP0006054_spinal_hemorrhage | 1.22682433 |
| 63 | MP0001905_abnormal_dopamine_level | 1.21741197 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.19105052 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.18809869 |
| 66 | MP0005165_increased_susceptibility_to | 1.18299387 |
| 67 | MP0009763_increased_sensitivity_to | 1.17382166 |
| 68 | MP0001756_abnormal_urination | 1.17363532 |
| 69 | MP0004947_skin_inflammation | 1.16767856 |
| 70 | MP0002693_abnormal_pancreas_physiology | 1.16654549 |
| 71 | MP0005310_abnormal_salivary_gland | 1.13355928 |
| 72 | MP0003011_delayed_dark_adaptation | 1.13151434 |
| 73 | MP0001663_abnormal_digestive_system | 1.12623566 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.11958931 |
| 75 | MP0002006_tumorigenesis | 1.11397611 |
| 76 | MP0000858_altered_metastatic_potential | 1.10326808 |
| 77 | MP0000609_abnormal_liver_physiology | 1.08230025 |
| 78 | MP0009643_abnormal_urine_homeostasis | 1.07749610 |
| 79 | MP0002254_reproductive_system_inflammat | 1.07734496 |
| 80 | MP0002998_abnormal_bone_remodeling | 1.07505657 |
| 81 | MP0003638_abnormal_response/metabolism_ | 1.06689869 |
| 82 | MP0002398_abnormal_bone_marrow | 1.05457285 |
| 83 | MP0005451_abnormal_body_composition | 1.04780894 |
| 84 | MP0003690_abnormal_glial_cell | 1.04470718 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 1.04221883 |
| 86 | MP0004782_abnormal_surfactant_physiolog | 1.03199587 |
| 87 | MP0002132_abnormal_respiratory_system | 1.02979855 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01959205 |
| 89 | MP0002429_abnormal_blood_cell | 1.00585584 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 1.00111462 |
| 91 | MP0005164_abnormal_response_to | 0.99385452 |
| 92 | MP0002166_altered_tumor_susceptibility | 0.99031964 |
| 93 | MP0000689_abnormal_spleen_morphology | 0.98701307 |
| 94 | MP0000230_abnormal_systemic_arterial | 0.98637321 |
| 95 | MP0002118_abnormal_lipid_homeostasis | 0.98595948 |
| 96 | MP0002933_joint_inflammation | 0.98089597 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.97003976 |
| 98 | MP0003763_abnormal_thymus_physiology | 0.94123919 |
| 99 | MP0001542_abnormal_bone_strength | 0.93009782 |
| 100 | MP0005410_abnormal_fertilization | 0.91699441 |
| 101 | MP0005166_decreased_susceptibility_to | 0.91633982 |
| 102 | MP0003866_abnormal_defecation | 0.91540084 |
| 103 | MP0000604_amyloidosis | 0.91139275 |
| 104 | MP0005220_abnormal_exocrine_pancreas | 0.88253497 |
| 105 | MP0008872_abnormal_physiological_respon | 0.85896452 |
| 106 | MP0005636_abnormal_mineral_homeostasis | 0.85554058 |
| 107 | MP0010386_abnormal_urinary_bladder | 0.85162534 |
| 108 | MP0002876_abnormal_thyroid_physiology | 0.84038059 |
| 109 | MP0002722_abnormal_immune_system | 0.83384537 |
| 110 | MP0000372_irregular_coat_pigmentation | 0.82309312 |
| 111 | MP0001986_abnormal_taste_sensitivity | 0.81863561 |
| 112 | MP0005408_hypopigmentation | 0.80331244 |
| 113 | MP0000920_abnormal_myelination | 0.79621036 |
| 114 | MP0004510_myositis | 0.79540175 |
| 115 | MP0005390_skeleton_phenotype | 0.79345323 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.78541131 |
| 117 | MP0002295_abnormal_pulmonary_circulatio | 0.78519116 |
| 118 | MP0003448_altered_tumor_morphology | 0.78178318 |
| 119 | MP0005075_abnormal_melanosome_morpholog | 0.77987628 |
| 120 | MP0005535_abnormal_body_temperature | 0.77488920 |
| 121 | MP0001545_abnormal_hematopoietic_system | 0.77247535 |
| 122 | MP0005397_hematopoietic_system_phenotyp | 0.77247535 |
| 123 | MP0009642_abnormal_blood_homeostasis | 0.75570799 |
| 124 | MP0000249_abnormal_blood_vessel | 0.75240348 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.75187647 |
| 126 | MP0003828_pulmonary_edema | 0.74626589 |
| 127 | MP0005381_digestive/alimentary_phenotyp | 0.74446091 |
| 128 | MP0000598_abnormal_liver_morphology | 0.72393839 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.72241085 |
| 130 | MP0005174_abnormal_tail_pigmentation | 0.72126202 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.06089708 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.97084670 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 4.87753866 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.65392330 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.62600719 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.23744972 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.88034320 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.82389601 |
| 9 | Prolonged bleeding time (HP:0003010) | 3.74389504 |
| 10 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.54695751 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.33781298 |
| 12 | Recurrent skin infections (HP:0001581) | 3.22729321 |
| 13 | Joint hemorrhage (HP:0005261) | 3.17178969 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.10156559 |
| 15 | Mediastinal lymphadenopathy (HP:0100721) | 3.08681402 |
| 16 | Dysostosis multiplex (HP:0000943) | 3.07562189 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.04700795 |
| 18 | Autoimmune thrombocytopenia (HP:0001973) | 3.02589495 |
| 19 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.01470927 |
| 20 | Mitochondrial inheritance (HP:0001427) | 2.96811820 |
| 21 | Loss of speech (HP:0002371) | 2.93273611 |
| 22 | Glomerulonephritis (HP:0000099) | 2.90974030 |
| 23 | Menorrhagia (HP:0000132) | 2.87698741 |
| 24 | Progressive neurologic deterioration (HP:0002344) | 2.85890251 |
| 25 | Acute encephalopathy (HP:0006846) | 2.79034902 |
| 26 | Myositis (HP:0100614) | 2.76357456 |
| 27 | Hepatocellular necrosis (HP:0001404) | 2.76134109 |
| 28 | Basal ganglia calcification (HP:0002135) | 2.73831647 |
| 29 | Stomatitis (HP:0010280) | 2.71536403 |
| 30 | Generalized aminoaciduria (HP:0002909) | 2.69545567 |
| 31 | Progressive macrocephaly (HP:0004481) | 2.67955260 |
| 32 | Increased cerebral lipofuscin (HP:0011813) | 2.67892115 |
| 33 | Vasculitis (HP:0002633) | 2.65714981 |
| 34 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.63847243 |
| 35 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.63847243 |
| 36 | Axonal loss (HP:0003447) | 2.63302878 |
| 37 | Gingivitis (HP:0000230) | 2.62412024 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.58947969 |
| 39 | Petechiae (HP:0000967) | 2.55329446 |
| 40 | Complement deficiency (HP:0004431) | 2.54097639 |
| 41 | Gingival bleeding (HP:0000225) | 2.53586034 |
| 42 | Xanthomatosis (HP:0000991) | 2.53520669 |
| 43 | Increased IgM level (HP:0003496) | 2.52234570 |
| 44 | Obstructive lung disease (HP:0006536) | 2.49970309 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 2.49970309 |
| 46 | Polyphagia (HP:0002591) | 2.48013686 |
| 47 | Reduced antithrombin III activity (HP:0001976) | 2.47880153 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47353182 |
| 49 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.45326794 |
| 50 | Abnormality of glycolipid metabolism (HP:0010969) | 2.45326794 |
| 51 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.45326794 |
| 52 | Urticaria (HP:0001025) | 2.43228108 |
| 53 | Intrahepatic cholestasis (HP:0001406) | 2.43099757 |
| 54 | Poor head control (HP:0002421) | 2.42517290 |
| 55 | Abnormality of the common coagulation pathway (HP:0010990) | 2.40114684 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39168207 |
| 57 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.38407614 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.38392341 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.37415889 |
| 60 | Mucopolysacchariduria (HP:0008155) | 2.34891786 |
| 61 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.34891786 |
| 62 | Purpura (HP:0000979) | 2.34324327 |
| 63 | Increased CSF lactate (HP:0002490) | 2.32485151 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.30564847 |
| 65 | Recurrent pneumonia (HP:0006532) | 2.29840500 |
| 66 | Increased intramyocellular lipid droplets (HP:0012240) | 2.25607525 |
| 67 | Prolonged neonatal jaundice (HP:0006579) | 2.23450865 |
| 68 | Hypergammaglobulinemia (HP:0010702) | 2.23366434 |
| 69 | Abnormal ciliary motility (HP:0012262) | 2.23219637 |
| 70 | Periodontitis (HP:0000704) | 2.21105765 |
| 71 | Orchitis (HP:0100796) | 2.20314048 |
| 72 | Mutism (HP:0002300) | 2.18795350 |
| 73 | Increased muscle lipid content (HP:0009058) | 2.18226250 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.16370329 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16191876 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16191876 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16191876 |
| 78 | Abnormality of complement system (HP:0005339) | 2.16055591 |
| 79 | Chronic otitis media (HP:0000389) | 2.15446558 |
| 80 | Dicarboxylic aciduria (HP:0003215) | 2.14423654 |
| 81 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14423654 |
| 82 | Nuclear cataract (HP:0100018) | 2.14087869 |
| 83 | Fat malabsorption (HP:0002630) | 2.13865498 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.12054358 |
| 85 | Nasal polyposis (HP:0100582) | 2.10144385 |
| 86 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.09405585 |
| 87 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.09405585 |
| 88 | Recurrent viral infections (HP:0004429) | 2.08379516 |
| 89 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.08076533 |
| 90 | Meningitis (HP:0001287) | 2.07317219 |
| 91 | Steatorrhea (HP:0002570) | 2.07291016 |
| 92 | Amyloidosis (HP:0011034) | 2.06529244 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.06104228 |
| 94 | Epistaxis (HP:0000421) | 2.05807413 |
| 95 | Respiratory failure (HP:0002878) | 2.05551934 |
| 96 | Cerebral palsy (HP:0100021) | 2.03335411 |
| 97 | Exertional dyspnea (HP:0002875) | 2.02643818 |
| 98 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02276998 |
| 99 | Myocardial infarction (HP:0001658) | 2.02154654 |
| 100 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.01340197 |
| 101 | Abnormality of the intrinsic pathway (HP:0010989) | 2.00155598 |
| 102 | Type I transferrin isoform profile (HP:0003642) | 1.99149030 |
| 103 | Abnormal platelet volume (HP:0011876) | 1.98175172 |
| 104 | Increased mean platelet volume (HP:0011877) | 1.97963340 |
| 105 | Cerebral edema (HP:0002181) | 1.97587385 |
| 106 | Retrobulbar optic neuritis (HP:0100654) | 1.96802126 |
| 107 | Optic neuritis (HP:0100653) | 1.96802126 |
| 108 | Renal Fanconi syndrome (HP:0001994) | 1.95146723 |
| 109 | Hyperlipoproteinemia (HP:0010980) | 1.94098884 |
| 110 | Increased serum ferritin (HP:0003281) | 1.93934481 |
| 111 | Abnormality of methionine metabolism (HP:0010901) | 1.93379341 |
| 112 | Pustule (HP:0200039) | 1.92749475 |
| 113 | Esophageal neoplasm (HP:0100751) | 1.91467844 |
| 114 | Neoplasm of head and neck (HP:0012288) | 1.91467844 |
| 115 | Autoimmune hemolytic anemia (HP:0001890) | 1.91142217 |
| 116 | Impaired platelet aggregation (HP:0003540) | 1.90414397 |
| 117 | Abnormal platelet function (HP:0011869) | 1.90414397 |
| 118 | Recurrent cutaneous fungal infections (HP:0011370) | 1.89600569 |
| 119 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.89600569 |
| 120 | Lactic acidosis (HP:0003128) | 1.89465642 |
| 121 | Pathologic fracture (HP:0002756) | 1.88681560 |
| 122 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.88025715 |
| 123 | Glycosuria (HP:0003076) | 1.86925312 |
| 124 | Abnormality of urine glucose concentration (HP:0011016) | 1.86925312 |
| 125 | Thrombocytosis (HP:0001894) | 1.84897649 |
| 126 | Vertebral compression fractures (HP:0002953) | 1.84868021 |
| 127 | Abnormality of lateral ventricle (HP:0030047) | 1.84332106 |
| 128 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.84315538 |
| 129 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84137198 |
| 130 | Joint swelling (HP:0001386) | 1.84095412 |
| 131 | Abnormality of T cell number (HP:0011839) | 1.83082341 |
| 132 | Nausea (HP:0002018) | 1.82816965 |
| 133 | Episodic fever (HP:0001954) | 1.82538697 |
| 134 | Abnormality of T cell physiology (HP:0011840) | 1.81317039 |
| 135 | Spontaneous hematomas (HP:0007420) | 1.81293442 |
| 136 | Abnormality of iron homeostasis (HP:0011031) | 1.81216853 |
| 137 | Hepatic necrosis (HP:0002605) | 1.81117581 |
| 138 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.80102100 |
| 139 | Abnormal pupillary function (HP:0007686) | 1.80075866 |
| 140 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.79856334 |
| 141 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79810228 |
| 142 | Pancreatitis (HP:0001733) | 1.79609473 |
| 143 | Nephritis (HP:0000123) | 1.78542578 |
| 144 | Opisthotonus (HP:0002179) | 1.77155122 |
| 145 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.76367315 |
| 146 | Delusions (HP:0000746) | 1.75436787 |
| 147 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.74739512 |
| 148 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.74570170 |
| 149 | Malnutrition (HP:0004395) | 1.74129690 |
| 150 | Growth hormone excess (HP:0000845) | 1.73231638 |
| 151 | Hypokinesia (HP:0002375) | 1.72168425 |
| 152 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71749136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.76522221 |
| 2 | IRAK4 | 3.46945188 |
| 3 | TESK2 | 3.23167552 |
| 4 | PBK | 3.17101298 |
| 5 | IRAK3 | 2.90989344 |
| 6 | TBK1 | 2.83864541 |
| 7 | NME2 | 2.76211360 |
| 8 | TYK2 | 2.72541407 |
| 9 | TESK1 | 2.70733558 |
| 10 | BLK | 2.60437504 |
| 11 | IKBKE | 2.31292969 |
| 12 | ERN1 | 2.26272861 |
| 13 | VRK2 | 2.25447410 |
| 14 | BMPR1B | 2.24579111 |
| 15 | RIPK4 | 2.20153565 |
| 16 | PIM2 | 2.16905505 |
| 17 | IKBKB | 2.14627938 |
| 18 | MAPKAPK3 | 1.91636096 |
| 19 | MAPK15 | 1.91170417 |
| 20 | KIT | 1.87769493 |
| 21 | TAOK3 | 1.82689118 |
| 22 | JAK3 | 1.82475312 |
| 23 | TAOK1 | 1.82201473 |
| 24 | TEC | 1.79998427 |
| 25 | MAP4K2 | 1.79434715 |
| 26 | MAP4K1 | 1.75628480 |
| 27 | LIMK1 | 1.74790549 |
| 28 | STK16 | 1.72469337 |
| 29 | BMPR2 | 1.72170759 |
| 30 | TXK | 1.67295490 |
| 31 | MST4 | 1.62047068 |
| 32 | BTK | 1.52520512 |
| 33 | INSRR | 1.50710737 |
| 34 | ZAP70 | 1.42253141 |
| 35 | BMX | 1.40210941 |
| 36 | PIK3CG | 1.40055693 |
| 37 | BCKDK | 1.38665127 |
| 38 | ILK | 1.34544865 |
| 39 | ADRBK2 | 1.33208555 |
| 40 | MAP2K6 | 1.31578167 |
| 41 | DAPK3 | 1.29076614 |
| 42 | SIK3 | 1.28358525 |
| 43 | CSF1R | 1.28040172 |
| 44 | MAP3K13 | 1.27582613 |
| 45 | SYK | 1.27367818 |
| 46 | JAK1 | 1.25377832 |
| 47 | IRAK1 | 1.24868231 |
| 48 | MST1R | 1.24605332 |
| 49 | TGFBR2 | 1.24549242 |
| 50 | ABL2 | 1.20257749 |
| 51 | NEK9 | 1.19875230 |
| 52 | FLT3 | 1.18374741 |
| 53 | LYN | 1.17097070 |
| 54 | GRK7 | 1.17085171 |
| 55 | CHUK | 1.16949003 |
| 56 | GRK1 | 1.16391206 |
| 57 | GRK5 | 1.16202445 |
| 58 | DAPK1 | 1.12342347 |
| 59 | TRIM28 | 1.07752550 |
| 60 | IRAK2 | 1.07643562 |
| 61 | DAPK2 | 1.04623019 |
| 62 | EPHB2 | 1.04518602 |
| 63 | ARAF | 1.02497627 |
| 64 | CSK | 1.00937002 |
| 65 | LCK | 0.96020411 |
| 66 | NLK | 0.93983138 |
| 67 | LRRK2 | 0.91191813 |
| 68 | PTK2B | 0.90686637 |
| 69 | ERBB3 | 0.90615145 |
| 70 | EPHB1 | 0.88383859 |
| 71 | TLK1 | 0.86462783 |
| 72 | LMTK2 | 0.86118564 |
| 73 | HCK | 0.81951074 |
| 74 | EIF2AK2 | 0.81778388 |
| 75 | ACVR1B | 0.81297526 |
| 76 | FGFR4 | 0.78881883 |
| 77 | JAK2 | 0.77165398 |
| 78 | CLK1 | 0.76413872 |
| 79 | CDK19 | 0.75424291 |
| 80 | PAK1 | 0.75244173 |
| 81 | MUSK | 0.73851771 |
| 82 | EPHA3 | 0.73476766 |
| 83 | PRKCQ | 0.72368939 |
| 84 | MAP2K2 | 0.71044006 |
| 85 | EIF2AK3 | 0.69253265 |
| 86 | PAK4 | 0.67407477 |
| 87 | MAP2K3 | 0.66537416 |
| 88 | PRKG2 | 0.66200705 |
| 89 | TGFBR1 | 0.66190440 |
| 90 | ITK | 0.64800439 |
| 91 | VRK1 | 0.64329945 |
| 92 | PRKCD | 0.63928584 |
| 93 | MAP3K3 | 0.63232768 |
| 94 | MAP3K5 | 0.63028400 |
| 95 | DDR2 | 0.62338377 |
| 96 | MET | 0.56886561 |
| 97 | MAP3K1 | 0.56764099 |
| 98 | PDK2 | 0.55095874 |
| 99 | YES1 | 0.54201128 |
| 100 | FGR | 0.52973062 |
| 101 | PRKD1 | 0.52156751 |
| 102 | CSNK1G3 | 0.52059824 |
| 103 | RPS6KA5 | 0.50516169 |
| 104 | CAMK2G | 0.50084535 |
| 105 | FRK | 0.49782332 |
| 106 | EIF2AK1 | 0.49526422 |
| 107 | PIM1 | 0.49466688 |
| 108 | HIPK2 | 0.48730874 |
| 109 | MAP3K12 | 0.48180275 |
| 110 | PINK1 | 0.47222965 |
| 111 | MAP3K11 | 0.47157610 |
| 112 | MAPK12 | 0.46962962 |
| 113 | ABL1 | 0.46145479 |
| 114 | TIE1 | 0.45442763 |
| 115 | GRK6 | 0.45112569 |
| 116 | ADRBK1 | 0.44989743 |
| 117 | TNIK | 0.44046561 |
| 118 | MAPK4 | 0.43144879 |
| 119 | PDPK1 | 0.40972693 |
| 120 | DYRK1B | 0.40778639 |
| 121 | CAMK2D | 0.40403031 |
| 122 | TRPM7 | 0.40098782 |
| 123 | FER | 0.39146821 |
| 124 | MAPKAPK5 | 0.37991500 |
| 125 | MOS | 0.37318352 |
| 126 | RPS6KA6 | 0.36156227 |
| 127 | BRAF | 0.35716581 |
| 128 | MATK | 0.35704073 |
| 129 | STK10 | 0.35503425 |
| 130 | MAPKAPK2 | 0.35389855 |
| 131 | PASK | 0.34263656 |
| 132 | PRKCA | 0.34235569 |
| 133 | PRKACG | 0.34129359 |
| 134 | KDR | 0.33496913 |
| 135 | EGFR | 0.33198705 |
| 136 | STK4 | 0.32491233 |
| 137 | CDC42BPA | 0.31959130 |
| 138 | CASK | 0.31918340 |
| 139 | NUAK1 | 0.31847901 |
| 140 | IGF1R | 0.31760145 |
| 141 | PKN1 | 0.31539841 |
| 142 | MYLK | 0.30546702 |
| 143 | TAOK2 | 0.30292630 |
| 144 | FES | 0.29330865 |
| 145 | TNK2 | 0.28684388 |
| 146 | ERBB4 | 0.27135939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.82150155 |
| 2 | Protein export_Homo sapiens_hsa03060 | 2.65421815 |
| 3 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.49041838 |
| 4 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.45557995 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.31538523 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16626738 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.15586631 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.03540011 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00180762 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.90559420 |
| 11 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.87106098 |
| 12 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.80702968 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.76735600 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.73329649 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.70240546 |
| 16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.69522480 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.68725709 |
| 18 | Legionellosis_Homo sapiens_hsa05134 | 1.68596790 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67056851 |
| 20 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.65414416 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.63165554 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62457389 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.60158746 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.58103050 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.57181561 |
| 26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.56502117 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51368096 |
| 28 | Peroxisome_Homo sapiens_hsa04146 | 1.49016960 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.47761764 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.47690329 |
| 31 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.45188117 |
| 32 | Huntingtons disease_Homo sapiens_hsa05016 | 1.44819615 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.41935312 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.41236640 |
| 35 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39256109 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.38909503 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.37130819 |
| 38 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33450565 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.33400138 |
| 40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.31489656 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.31223616 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29647966 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24886890 |
| 44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.19753031 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17054793 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.15764484 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.13510805 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.12619992 |
| 49 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.10697599 |
| 50 | Mineral absorption_Homo sapiens_hsa04978 | 1.08288382 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.08131083 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 1.05819374 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.05753243 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.05282663 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.03306057 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.01812865 |
| 57 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.01559679 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.01024039 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.99596363 |
| 60 | Proteasome_Homo sapiens_hsa03050 | 0.99424515 |
| 61 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97799010 |
| 62 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.97019644 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 0.95768484 |
| 64 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95190303 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.94215348 |
| 66 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93192229 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.92688276 |
| 68 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.92215959 |
| 69 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90510097 |
| 70 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.89497824 |
| 71 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89464103 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.89417871 |
| 73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89015486 |
| 74 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88956300 |
| 75 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.88911714 |
| 76 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86341735 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.85161531 |
| 78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84776170 |
| 79 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.84566587 |
| 80 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.81020880 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.80695230 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79833841 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.79424244 |
| 84 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78917580 |
| 85 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.78096247 |
| 86 | Ribosome_Homo sapiens_hsa03010 | 0.78080357 |
| 87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77809274 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.77104165 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72304863 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71218144 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70682278 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.70270571 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69883214 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.69224349 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.69217851 |
| 96 | ABC transporters_Homo sapiens_hsa02010 | 0.69110122 |
| 97 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.68312802 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66840604 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65873135 |
| 100 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65806544 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.64758636 |
| 102 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64611605 |
| 103 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64354772 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.63488021 |
| 105 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63249869 |
| 106 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.62830523 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60488746 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60009608 |
| 109 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.56615898 |
| 110 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56570959 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.56179654 |
| 112 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.55621564 |
| 113 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55134163 |
| 114 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.55077272 |
| 115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54509887 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.54246383 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.54193548 |
| 118 | Parkinsons disease_Homo sapiens_hsa05012 | 0.53503560 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.53414900 |
| 120 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.52729169 |
| 121 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.51553432 |
| 122 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.50770897 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.48571596 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.48193413 |
| 125 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47137478 |
| 126 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46956508 |
| 127 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44821978 |

